Aarash Bordbar 8/11/26 Aarash Bordbar 8/11/26 In The News: NIH Features Sinopia’s Science Translational Medicine Publication in Weekly Newsletter “Research Matters” Read More Aarash Bordbar 7/15/26 Aarash Bordbar 7/15/26 Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease Read More Aarash Bordbar 7/9/26 Aarash Bordbar 7/9/26 In The News: San Diego Business Journal Covers Sinopia’s Seed Financing and Lead Program in Parkinson’s disease Read More Aarash Bordbar 3/24/26 Aarash Bordbar 3/24/26 Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology Read More Aarash Bordbar 3/3/26 Aarash Bordbar 3/3/26 Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders Read More Aarash Bordbar 1/27/26 Aarash Bordbar 1/27/26 Sinopia Biosciences Strengthens Intellectual Property Estate with Issuance of Composition of Matter Patent Read More Aarash Bordbar 12/30/25 Aarash Bordbar 12/30/25 Sinopia Biosciences Awarded NIGMS Grant to Advance LEADS® Platform for Data-Driven Drug Discovery Read More Aarash Bordbar 4/1/25 Aarash Bordbar 4/1/25 In The News: Sinopia Biosciences selected as 2025 Cool Company by CONNECT Read More Aarash Bordbar 9/12/24 Aarash Bordbar 9/12/24 Sinopia Secures Phase II SBIR Grant from the National Institute of Dental and Craniofacial Research for Oral Mucositis Read More Aarash Bordbar 5/30/24 Aarash Bordbar 5/30/24 Sinopia Secures Grant Funding from the National Institutes of General Medical Sciences to Advance Proprietary Metabolomics Platform Read More Aarash Bordbar 4/19/23 Aarash Bordbar 4/19/23 Sinopia Biosciences Selects Lead Clinical Candidate, Secures Funding to Advance into the Clinic for Parkinson’s Disease Read More Aarash Bordbar 2/23/23 Aarash Bordbar 2/23/23 Sinopia Awarded Grant from National Institute of Dental and Craniofacial Research for Oral Mucositis Read More Aarash Bordbar 9/27/21 Aarash Bordbar 9/27/21 Sinopia Biosciences Awarded NIH Grant to Support Development of Parkinson’s Disease Pipeline Read More Aarash Bordbar 6/16/21 Aarash Bordbar 6/16/21 Sinopia Biosciences Awarded Grant from National Institute of General Medical Sciences for Metabolomics-Based High-Throughput Screening Read More Aarash Bordbar 5/1/20 Aarash Bordbar 5/1/20 Sinopia Biosciences Receives Grant from The Michael J. Fox Foundation to Advance Novel Treatment for Parkinson’s Disease Read More Aarash Bordbar 5/1/20 Aarash Bordbar 5/1/20 In The News: Sinopia Biosciences highlighted on The Michael J. Fox Foundation’s website Read More Aarash Bordbar 7/3/19 Aarash Bordbar 7/3/19 Sinopia Biosciences Joins NVIDIA Inception Program Read More Aarash Bordbar 5/3/19 Aarash Bordbar 5/3/19 Sinopia Biosciences Awarded Phase II SBIR to Focus on Drug Side Effects Read More Aarash Bordbar 10/1/18 Aarash Bordbar 10/1/18 Sinopia Biosciences and Omix Technologies Awarded NIGMS Phase I SBIR to Develop Next-Gen Drug Discovery Platform Read More Aarash Bordbar 9/13/16 Aarash Bordbar 9/13/16 Sinopia Biosciences Awarded NIGMS Phase I SBIR Read More
Aarash Bordbar 8/11/26 Aarash Bordbar 8/11/26 In The News: NIH Features Sinopia’s Science Translational Medicine Publication in Weekly Newsletter “Research Matters” Read More
Aarash Bordbar 7/15/26 Aarash Bordbar 7/15/26 Sinopia Biosciences Publishes Preclinical Data in Science Translational Medicine Supporting SB-0110, a Novel PKA-II Modulator, for Parkinson's Disease Read More
Aarash Bordbar 7/9/26 Aarash Bordbar 7/9/26 In The News: San Diego Business Journal Covers Sinopia’s Seed Financing and Lead Program in Parkinson’s disease Read More
Aarash Bordbar 3/24/26 Aarash Bordbar 3/24/26 Sinopia Biosciences Awarded NCI Grant to Advance LEADS® Drug Discovery Platform for Oncology Read More
Aarash Bordbar 3/3/26 Aarash Bordbar 3/3/26 Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders Read More
Aarash Bordbar 1/27/26 Aarash Bordbar 1/27/26 Sinopia Biosciences Strengthens Intellectual Property Estate with Issuance of Composition of Matter Patent Read More
Aarash Bordbar 12/30/25 Aarash Bordbar 12/30/25 Sinopia Biosciences Awarded NIGMS Grant to Advance LEADS® Platform for Data-Driven Drug Discovery Read More
Aarash Bordbar 4/1/25 Aarash Bordbar 4/1/25 In The News: Sinopia Biosciences selected as 2025 Cool Company by CONNECT Read More
Aarash Bordbar 9/12/24 Aarash Bordbar 9/12/24 Sinopia Secures Phase II SBIR Grant from the National Institute of Dental and Craniofacial Research for Oral Mucositis Read More
Aarash Bordbar 5/30/24 Aarash Bordbar 5/30/24 Sinopia Secures Grant Funding from the National Institutes of General Medical Sciences to Advance Proprietary Metabolomics Platform Read More
Aarash Bordbar 4/19/23 Aarash Bordbar 4/19/23 Sinopia Biosciences Selects Lead Clinical Candidate, Secures Funding to Advance into the Clinic for Parkinson’s Disease Read More
Aarash Bordbar 2/23/23 Aarash Bordbar 2/23/23 Sinopia Awarded Grant from National Institute of Dental and Craniofacial Research for Oral Mucositis Read More
Aarash Bordbar 9/27/21 Aarash Bordbar 9/27/21 Sinopia Biosciences Awarded NIH Grant to Support Development of Parkinson’s Disease Pipeline Read More
Aarash Bordbar 6/16/21 Aarash Bordbar 6/16/21 Sinopia Biosciences Awarded Grant from National Institute of General Medical Sciences for Metabolomics-Based High-Throughput Screening Read More
Aarash Bordbar 5/1/20 Aarash Bordbar 5/1/20 Sinopia Biosciences Receives Grant from The Michael J. Fox Foundation to Advance Novel Treatment for Parkinson’s Disease Read More
Aarash Bordbar 5/1/20 Aarash Bordbar 5/1/20 In The News: Sinopia Biosciences highlighted on The Michael J. Fox Foundation’s website Read More
Aarash Bordbar 7/3/19 Aarash Bordbar 7/3/19 Sinopia Biosciences Joins NVIDIA Inception Program Read More
Aarash Bordbar 5/3/19 Aarash Bordbar 5/3/19 Sinopia Biosciences Awarded Phase II SBIR to Focus on Drug Side Effects Read More
Aarash Bordbar 10/1/18 Aarash Bordbar 10/1/18 Sinopia Biosciences and Omix Technologies Awarded NIGMS Phase I SBIR to Develop Next-Gen Drug Discovery Platform Read More
Aarash Bordbar 9/13/16 Aarash Bordbar 9/13/16 Sinopia Biosciences Awarded NIGMS Phase I SBIR Read More
